{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:36:20Z","timestamp":1786995380647,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ophtha.2010.06.041","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T04:53:39Z","timestamp":1285908819000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis"],"prefix":"10.1016","volume":"118","author":[{"given":"Yasin A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata T.","family":"Kashiwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suy Anne","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Castro-Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kalyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Flikier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.06.041_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/bjo.69.10.778","article-title":"Acanthamoeba keratitis successfully treated medically","volume":"69","author":"Wright","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0161-6420(97)30092-X","article-title":"Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine","volume":"104","author":"Duguid","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.06.041_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0161-6420(99)00515-1","article-title":"Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis","volume":"106","author":"Hargrave","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.06.041_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0161-6420(03)00481-0","article-title":"Persistently culture positive Acanthamoeba keratitis: in vivo resistance and in vitro sensitivity","volume":"110","author":"P\u00e9rez-Santonja","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.06.041_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004397-198902930-00001","article-title":"Complications of topical antimicrobial agents","volume":"29","author":"Stern","year":"1989","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2010.06.041_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00417-009-1103-9","article-title":"Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment","volume":"247","author":"Shi","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/eye.1993.168","article-title":"A review of 72 consecutive cases of Acanthamoeba keratitis, 1984\u20131992","volume":"7","author":"Bacon","year":"1993","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2010.06.041_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ico.0000138839.29823.57","article-title":"Trends in contact lens-related corneal ulcers","volume":"24","author":"Mah-Sadorra","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2010.06.041_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3347\/kjp.2006.44.4.313","article-title":"Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear","volume":"44","author":"Lee","year":"2006","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1442-9071.2004.00911.x","article-title":"Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997\u20132002","volume":"33","author":"Butler","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ophtha.2005.12.022","article-title":"Tandem scanning confocal corneal microscopy in the diagnosis of suspected Acanthamoeba keratitis","volume":"113","author":"Parmar","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.06.041_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1442-9071.1991.tb01794.x","article-title":"The pathogenesis of Acanthamoeba keratitis","volume":"19","author":"Badenoch","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib13","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1128\/jcm.28.12.2722-2725.1990","article-title":"Laboratory investigation of Acanthamoeba keratitis","volume":"28","author":"Kilvington","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","article-title":"Riboflavin\/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus","volume":"135","author":"Wollensak","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-2005-857950","article-title":"A new treatment of keratectasia after LASIK by using collagen with riboflavin\/UVA light cross-linking","volume":"222","author":"Kohlhaas","year":"2005","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2010.06.041_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2000-10344","article-title":"Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes: preliminary results in four patients","volume":"217","author":"Schnitzler","year":"2000","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2010.06.041_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exer.1997.0410","article-title":"Induction of cross-links in corneal tissue","volume":"66","author":"Spoerl","year":"1998","journal-title":"Exp Eye Res"},{"issue":"suppl","key":"10.1016\/j.ophtha.2010.06.041_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1423-0410.2000.tb00065.x","article-title":"The use of riboflavin for the inactivation of pathogens in blood products","volume":"78","author":"Goodrich","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.ophtha.2010.06.041_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-4274(85)90169-9","article-title":"Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical (O2-) mechanisms","volume":"26","author":"Joshi","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ophtha.2010.06.041_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1203\/00006450-197503000-00009","article-title":"In vitro studies of effects of light and riboflavin on DNA and HeLa cells","volume":"9","author":"Speck","year":"1975","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ophtha.2010.06.041_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1537-2995.2004.03355.x","article-title":"Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light","volume":"44","author":"Ruane","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.ophtha.2010.06.041_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.transci.2007.07.002","article-title":"Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light","volume":"37","author":"Cardo","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ophtha.2010.06.041_bib23","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1167\/iovs.07-1592","article-title":"Antimicrobial efficacy of riboflavin\/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis","volume":"49","author":"Martins","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2010.06.041_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrs.2005.12.092","article-title":"Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light","volume":"32","author":"Kohlhaas","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2010.06.041_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2007.08.040","article-title":"Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis","volume":"145","author":"Lim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(92)31994-3","article-title":"Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide","volume":"99","author":"Larkin","year":"1992","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.ophtha.2010.06.041_bib27","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.1093\/clind\/13.Supplement_5.S431","article-title":"In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba","volume":"13","author":"Osato","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ophtha.2010.06.041_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/eye.1994.137","article-title":"Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy","volume":"8","author":"Hay","year":"1994","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2010.06.041_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pt.2006.02.004","article-title":"The pathophysiology of Acanthamoeba keratitis","volume":"22","author":"Clarke","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0882-4010(03)00061-5","article-title":"Pathogenesis of Acanthamoeba infections","volume":"34","author":"Khan","year":"2003","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ophtha.2010.06.041_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00417-003-0805-7","article-title":"Delay in diagnosis and outcome of Acanthamoeba keratitis","volume":"242","author":"Claerhout","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/ICL.0b013e31814dabf5","article-title":"Acanthamoeba keratitis: 2007: a train wreck in slow motion","volume":"33","author":"Cavanagh","year":"2007","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ophtha.2010.06.041_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archopht.1988.01060130074031","article-title":"Corneal toxicity of propamidine","volume":"106","author":"Johns","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00003226-200203000-00026","article-title":"Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%)","volume":"21","author":"Murthy","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2010.06.041_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-0420.2004.00237.x","article-title":"Are cataract and iris atrophy toxic complications of medical treatment of Acanthamoeba keratitis?","volume":"82","author":"Ehlers","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2010.06.041_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/00221287-104-1-37","article-title":"Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis","volume":"104","author":"Jackett","year":"1978","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00013542-199401000-00003","article-title":"Acanthamoeba: biology, ecology and human disease","volume":"5","author":"Kilvington","year":"1994","journal-title":"Rev Med Microbiol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/archopht.1989.01070020590046","article-title":"Hydrogen peroxide damage to human corneal epithelial cells in vitro: implications for contact lens disinfection systems","volume":"107","author":"Tripathi","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.06.041_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/02713688208996348","article-title":"Toxic effects of hydrogen peroxide on corneal endothelium","volume":"2","author":"Riley","year":"1982","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2010.06.041_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ICO.0b013e318030df5a","article-title":"Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans","volume":"26","author":"Mazzotta","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2010.06.041_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003226-200401000-00008","article-title":"Keratocyte apoptosis after corneal collagen cross-linking using riboflavin\/UVA treatment","volume":"23","author":"Wollensak","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2010.06.041_bib42","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0886-3350(03)00343-2","article-title":"Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit","volume":"29","author":"Wollensak","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2010.06.041_bib43","first-page":"2235","article-title":"In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii","volume":"31","author":"He","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2010.06.041_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/ICO.0b013e3181bd9f8c","article-title":"Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus","volume":"29","author":"Goldich","year":"2010","journal-title":"Cornea"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201000713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201000713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:59:53Z","timestamp":1758981593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164201000713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S016164201000713X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.06.041","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}